Smartwatch-based Intervention for Cardiovascular Health (SWITCH)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBeijing Anzhen Hospital
About this trial
This study aims to employ a cluster randomized controlled trial to evaluate the effectiveness of an mHealth-Based Multi-faceted Cardiovascular Health Intervention Model among Overweight/Obese Individuals with Cardiometabolic Preconditions, thereby providing theoretical foundations and practical guidance for the prevention and management of this population.
Eligibility criteria
Qualifiers
Age >= 18 years, no gender restriction;
Overweight and obesity: Body Mass Index (BMI) 24.0-32.4 kg/m², or waist circumference >= 90 cm for males and >= 85 cm for females;
Disqualifiers
Secondary obesity diagnosed by doctors in secondary or higher-level medical institutions;
Cardiovascular and cerebrovascular diseases, including myocardial infarction, stroke, heart failure, arrhythmia; or having received coronary intervention therapy, cardiac surgery, etc.; or with a 10-year high risk of cardiovascular disease;
Diseases seriously affecting survival, such as malignant tumors, AIDS, hepatic and renal failure;
Pregnancy, lactation period, or women who may become pregnant within one year;
Trial design
Treatments tested in this trial
- Smartwatch-Based Multi-Faceted Behavioral Intervention Model Led by Exercise and Dietary Interventions, Supported by Primary Medical Staff, Along with the Distribution of Health Education Manuals
- Face-to-face health education sessions
Treatment groups
1,400 Participants
are divided into 2 treatment groupsSponsors and collaborators
Beijing Anzhen Hospital
Lead sponsor
Beijing Chao Yang Hospital
Collaborator
Cangzhou Central Hospital
Collaborator
Health Community Group of Yuhuan People's Hosptial
Collaborator
Source ClinicalTrials.gov